C-RAD announces today a partnership agreement with the Renova Oncology Group based in Hyderabad, India. The agreement includes an order for multiple Catalyst+ HD and Sentinel 4DCT systems and a…
Read More
C-RAD takes another important step in creating awareness for the importance of accurate patient positioning in advanced radiation therapy in this important market by setting up an Experience center. The…
Lars Levin has today been appointed Interim CFO for C-RAD AB (Publ) and thus replaces Henrik Bergentoft who, as previously announced, has resigned as CFO. Lars Levin comes most recently…
Lars Levin har idag utsetts till Interim CFO för C-RAD AB (Publ) och ersätter därmed Henrik Bergentoft som enligt det som tidigare meddelats har sagt upp sig som CFO. Lars…
Australia’s Global Centre for Research and Training in Radiation Oncology propels SGRT forward as standard of care by selecting C-RAD as an industry training partner The Global Centre for Research and…
TREDJE KVARTALET 2022 Orderingången minskade med 1 % till 80,9 (82,1) MSEK (-11 % i konstanta valutor). Orderstocken uppgick till 493,3 (372,2) MSEK. Intäkterna ökade med 32% till 83,5 (63,2)…
THIRD QUARTER 2022 Order intake decreased 1 % to 80.9 (82.1) MSEK (-11 % in constant currencies). Order backlog amounted to 493.3 (372.2) MSEK. Revenue increased 32% to 83.5 (63.2)…
Invitation to join the presentation of C-RAD’s third quarter 2022. Date: Friday October 28, 2022 / kl. 11:00 CEST Venue: Online Presentation Topic: C-RAD Interim Report Q3 2022 Procedure: Please…
UPPSALA, Sweden, October 20, 2022 – C-RAD is proud to announce their collaboration with the University of Arkansas for Medical Sciences (UAMS) to create the first demonstration site in the…
The decision for positioning technology in a country wide tender in Italy has been announced. The C-RAD distributor – Tecnosan SRL – placed first in the SGRT lot and third…